Request
Information

News

Read more about the latest updates
in Breast Health from Hologic®

 

Hologic Chosen Twice as Company of the Year

Hologic’s global leadership in women’s health, continued excellence in COVID-19 testing, and expanding impact on other areas of healthcare have earned ‘Company of the Year’ honors from both editors and readers of the industry news source MD+DI. And the reasons given by the judges align perfectly with Hologic’s goals and beliefs.

Read more
23 Feb 2022

An Unprecedented Study to Change Women’s Health

Year-one results of the Hologic Global Women’s Health Index are in and findings show there’s a Worldwide Disparity in Women’s Preventive Care

Read more
27 Sep 2021

Improving Women's Health together: World Economic Forum Membership

In recognition of Hologic's contributions women’s health around the globe, the World Economic Forum recently elevated our membership status to partner.

Read more
11 Oct 2021

Introducing the Global Women's Health Index

With a purpose, passion, and promise to the world, we created an unprecedented study for women everywhere. Stand with us. Be a part of world change.

Read more
8 Mar 2021

Press Release: Hologic® to Acquire Biotheranostics

Hologic® to acquire Biotheranostics, leader in molecular tests for breast and metastatic cancers, for approximately $230 Million

Read more
5 Jan 2021

Press Release: Hologic® Launches 3DQuorum™ Imaging Technology

Hologic® Launches 3DQuorum™ Imaging Technology, Powered by Genius AI™, in Europe

Read more
26 Oct 2020

Hologic’s Sustainability Leadership Makes Company “A Global Force for Good”

Hologic, Inc. published “A Global Force for Good,” a report detailing the Company’s environmental, social and governance (ESG) achievements in 2021.

Read more
24 Jan 2022

Hologic: A Leader In Sustainability

Hologic’s growing efforts have resulted in inclusion in the Dow Jones Sustainability North America Composite Index for the first time.

Read more
29 Nov 2021

Hologic Closes Acquisition of Mobidiag

Hologic has finalised the acquisition of Mobidiag, a developer of innovative molecular diagnostic tests and instrumentation.

Read more
17 Jun 2021

Advancing the Breast Continuum of Care

We are committed to advancing the Breast Continuum of Care, ensuring that every solution, from screening to monitoring, supports excellence in disease management all along the patient pathway.

Read more
17 Feb 2021

Press Release: Hologic® to Acquire SOMATEX

Hologic® to acquire SOMATEX, leader in biopsy site markers and localization technologies, for $64 Million

Read more
4 Jan 2021

Hologic® Showcased Latest Advances at Virtual ECR Congress 2020

Hologic, Inc. (Marlborough, MA, USA) showcased its latest advances and shared its new innovations on its virtual booth at the online ECR 2020 event held on July 15-21.

Read more
15 Jul 2020

Hologic Chosen Twice as Company of the Year

Hologic’s global leadership in women’s health, continued excellence in COVID-19 testing, and expanding impact on other areas of healthcare have earned ‘Company of the Year’ honors from both editors and readers of the industry news source MD+DI. And the reasons given by the judges align perfectly with Hologic’s goals and beliefs.

Read more
23 Feb 2022

Hologic’s Sustainability Leadership Makes Company “A Global Force for Good”

Hologic, Inc. published “A Global Force for Good,” a report detailing the Company’s environmental, social and governance (ESG) achievements in 2021.

Read more
24 Jan 2022

An Unprecedented Study to Change Women’s Health

Year-one results of the Hologic Global Women’s Health Index are in and findings show there’s a Worldwide Disparity in Women’s Preventive Care

Read more
27 Sep 2021

Hologic: A Leader In Sustainability

Hologic’s growing efforts have resulted in inclusion in the Dow Jones Sustainability North America Composite Index for the first time.

Read more
29 Nov 2021

Improving Women's Health together: World Economic Forum Membership

In recognition of Hologic's contributions women’s health around the globe, the World Economic Forum recently elevated our membership status to partner.

Read more
11 Oct 2021

Hologic Closes Acquisition of Mobidiag

Hologic has finalised the acquisition of Mobidiag, a developer of innovative molecular diagnostic tests and instrumentation.

Read more
17 Jun 2021

Introducing the Global Women's Health Index

With a purpose, passion, and promise to the world, we created an unprecedented study for women everywhere. Stand with us. Be a part of world change.

Read more
8 Mar 2021

Advancing the Breast Continuum of Care

We are committed to advancing the Breast Continuum of Care, ensuring that every solution, from screening to monitoring, supports excellence in disease management all along the patient pathway.

Read more
17 Feb 2021

Press Release: Hologic® to Acquire Biotheranostics

Hologic® to acquire Biotheranostics, leader in molecular tests for breast and metastatic cancers, for approximately $230 Million

Read more
5 Jan 2021

Press Release: Hologic® to Acquire SOMATEX

Hologic® to acquire SOMATEX, leader in biopsy site markers and localization technologies, for $64 Million

Read more
4 Jan 2021

Press Release: Hologic® Launches 3DQuorum™ Imaging Technology

Hologic® Launches 3DQuorum™ Imaging Technology, Powered by Genius AI™, in Europe

Read more
26 Oct 2020

Hologic® Showcased Latest Advances at Virtual ECR Congress 2020

Hologic, Inc. (Marlborough, MA, USA) showcased its latest advances and shared its new innovations on its virtual booth at the online ECR 2020 event held on July 15-21.

Read more
15 Jul 2020

Product Notice

You are about to access medical systems information on the Hologic 3Dimensions™ Mammography System European Website. Product availability differs by region and country and is subject to varied regulatory requirements.

The content of this site is reserved for Health Care Professionals only.

I am a Health Care Professional or similar.

Je suis un professionnel de santé ou assimilé.

Je ne suis pas un professionnel de santé ou assimilé.